Authors:
DENG DY
MCKNIGHT HC
MUENZER JT
EARLE JD
WHITE RWD
GUMERLOCK PH
Citation: Dy. Deng et al., RADIATION-RESISTANCE OF CARCINOMA OF THE PROSTATE CORRELATES WITH ACTIVATION OF THE P53 PATHWAY, Journal of investigative medicine, 46(1), 1998, pp. 126-126
Authors:
MACK PC
CHI SG
MEYERS FJ
STEWART SL
WHITE RWD
GUMERLOCK PH
Citation: Pc. Mack et al., INCREASED RB1 ABNORMALITIES IN HUMAN PRIMARY PROSTATE-CANCER FOLLOWING COMBINED ANDROGEN BLOCKADE, The Prostate, 34(2), 1998, pp. 145-151
Citation: Fj. Meyers et Rwd. White, PROSTATE CARCINOMA - CLARIFICATION THROUGH CLINICAL INSIGHT AND MOLECULAR DIAGNOSTICS, Western journal of medicine, 168(6), 1998, pp. 525-525
Authors:
WHITE RWD
DEITCH AD
JACKSON AG
GANDOUREDWARDS R
MARSHALLECK J
SOARES SE
TOSCANO SN
LUNETTA JM
STEWART SL
Citation: Rwd. White et al., RACIAL-DIFFERENCES IN CLINICALLY LOCALIZED PROSTATE CANCERS OF BLACK-AND-WHITE MEN, The Journal of urology, 159(6), 1998, pp. 1979-1983
Authors:
RADEMACHER DE
DEITCH AD
GANDOUREDWARDS R
WHITE RWD
MILLER GJ
JACKSON AG
MERSHALLECK J
KIM KB
Citation: De. Rademacher et al., MOLECULAR MARKERS IN BENIGN PROSTATIC HYPERPLASIA (BPH) FROM DIFFERENT ETHNIC-GROUPS, The Journal of urology, 159(5), 1998, pp. 403-403
Authors:
KAPLAN S
MELMAN A
FOWLER J
GILHOOLY P
GARVIN D
KOPPEL M
WHITE C
FLANAGAN M
MILSTEN R
WHITE RWD
WALDSTREICHER J
LEE M
Citation: S. Kaplan et al., BASE-LINE SYMPTOM SEVERITY AND ITS RELATIONSHIP TO LONG-TERM RESPONSETO FINASTERIDE, The Journal of urology, 159(5), 1998, pp. 975-975
Authors:
GUMERLOCK PH
CHI SG
SHI XB
VOELLER HJ
JACOBSON JW
GELMANN EP
WHITE RWD
Citation: Ph. Gumerlock et al., P53 ABNORMALITIES IN PRIMARY PROSTATE-CANCER - SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS OF COMPLEMENTARY-DNA IN COMPARISON WITH GENOMIC DNA, Journal of the National Cancer Institute, 89(1), 1997, pp. 66-71
Citation: Sg. Chi et al., FREQUENT ALTERATION OF CDKN2 (P16(INK4A) MTS1) EXPRESSION IN HUMAN PRIMARY PROSTATE CARCINOMAS/, Clinical cancer research, 3(10), 1997, pp. 1889-1897
Authors:
TAN J
SHARIEF Y
HAMIL KG
GREGORY CW
ZANG DY
SAR M
GUMERLOCK PH
WHITE RWD
PRETLOW TG
HARRIS SE
WILSON EM
MOHLER JL
FRENCH FS
Citation: J. Tan et al., DEHYDROEPIANDROSTERONE ACTIVATES MUTANT ANDROGEN RECEPTORS EXPRESSED IN THE ANDROGEN-DEPENDENT HUMAN PROSTATE-CANCER XENOGRAFT CWR22 AND LNCAP CELLS, Molecular endocrinology, 11(4), 1997, pp. 450-459
Authors:
GUMERLOCK PH
CHI SG
MACK PC
MEYERS FJ
WHITE RWD
Citation: Ph. Gumerlock et al., MOLECULAR CHARACTERIZATION OF THE P53 AND RB1 TUMOR-SUPPRESSOR PATHWAYS IN HUMAN PROSTATE CARCINOMAS, Journal of investigative medicine, 44(1), 1996, pp. 135-135
Citation: Xb. Shi et al., IDENTIFICATION OF P53 MUTATIONS IN ARCHIVAL PROSTATE TUMORS - SENSITIVITY OF AN OPTIMIZED SINGLE-STRAND CONFORMATIONAL POLYMORPHISM (SSCP) ASSAY, Diagnostic molecular pathology, 5(4), 1996, pp. 271-278
Authors:
TRICOLI JV
GUMERLOCK PH
YAO JL
CHI SG
DSOUZA SA
NESTOK BR
WHITE RWD
FRENCH FS
GELMANN EP
PRETLOW TG
STEARNS ME
Citation: Jv. Tricoli et al., ALTERATIONS OF THE RETINOBLASTOMA GENE IN HUMAN PROSTATE ADENOCARCINOMA, Genes, chromosomes & cancer, 15(2), 1996, pp. 108-114
Authors:
LITWILLER SE
KIM KB
FONE PD
WHITE RWD
STONE AR
Citation: Se. Litwiller et al., POSTPROSTATECTOMY INCONTINENCE AND THE ARTIFICIAL URINARY SPHINCTER -A LONG-TERM STUDY OF PATIENT SATISFACTION AND CRITERIA FOR SUCCESS, The Journal of urology, 156(6), 1996, pp. 1975-1980
Authors:
BORCHERS H
MEYERS FJ
GUMERLOCK PH
STEWART SL
WHITE RWD
Citation: H. Borchers et al., NM23 GENE-EXPRESSION IN HUMAN PROSTATIC CARCINOMAS AND BENIGN PROSTATIC HYPERPLASIAS - ALTERED EXPRESSION IN COMBINED ANDROGEN BLOCKADED CARCINOMAS, The Journal of urology, 155(6), 1996, pp. 2080-2084
Citation: Sh. Glick et al., RELATIONSHIP OF P53 AND BCL-2 TO PROGNOSIS IN MUSCLE-INVASIVE TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, The Journal of urology, 155(5), 1996, pp. 1754-1757
Authors:
NAGABHUSHAN M
MILLER CM
PRETLOW TP
GIACONIA JM
EDGEHOUSE NL
SCHWARTZ S
KUNG HJ
WHITE RWD
GUMERLOCK PH
RESNICK MI
AMINI SB
PRETLOW TG
Citation: M. Nagabhushan et al., CWR22 - THE FIRST HUMAN PROSTATE-CANCER XENOGRAFT WITH STRONGLY ANDROGEN-DEPENDENT RELAPSED STRAINS BOTH IN-VIVO AND IN SOFT AGAR, Cancer research, 56(13), 1996, pp. 3042-3046
Authors:
SAROSDY MF
WHITE RWD
SOLOWAY MS
SHEINFELD J
HUDSON MA
SCHELLHAMMER PF
JAROWENKO MV
ADAMS G
BLUMENSTEIN BA
Citation: Mf. Sarosdy et al., RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER, The Journal of urology, 154(2), 1995, pp. 379-383
Authors:
SAROSDY MF
WHITE RWD
SOLOWAY MS
SHEINFELD J
HUDSON MA
SCHELLHAMMER PF
JAROWENKO MV
ADAMS G
BLUMENSTEIN BA
Citation: Mf. Sarosdy et al., RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER - REPLY, The Journal of urology, 154(2), 1995, pp. 384-384
Authors:
DENARDO SJ
GUMERLOCK PH
WINTHROP MD
MACK PC
CHI SG
LAMBORN KR
SHEN S
MIERS LA
WHITE RWD
DENARDO GL
Citation: Sj. Denardo et al., Y-90 CHIMERIC L6 THERAPY OF HUMAN BREAST-CANCER IN NUDE-MICE AND APOPTOSIS-RELATED MESSENGER-RNA EXPRESSION, Cancer research, 55(23), 1995, pp. 5837-5841
Authors:
CHI SG
WHITE RWD
MEYERS FJ
SIDERS DB
LEE F
GUMERLOCK PH
Citation: Sg. Chi et al., P53 IN PROSTATE-CANCER - FREQUENT EXPRESSED TRANSITION MUTATIONS, Journal of the National Cancer Institute, 86(12), 1994, pp. 926-933